Live Breaking News & Updates on Vivreon Gastrosciences

Stay updated with breaking news from Vivreon gastrosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

Etrasimod was effective and well tolerated as an induction and maintenance therapy
in patients with moderately to severely active ulcerative colitis. Etrasimod is a
treatment option with a unique combination of attributes that might address the persistent
unmet needs of patients with ulcerative colitis. ....

Boston , Massachusetts , United-states , Western-university , California , San-francisco , Cytoki-pharma , Eli-lilly , Exeliom-biosciences , Vivreon-gastrosciences , Ventyx-biosciences , Oppilan-pharma